Dementia News and Research

Latest Dementia News and Research

Synexus to develop effective clinical trials for Mild cognitive impairment

Mild cognitive impairment (MCI) is under the pharma' spotlight as the number of clinical trials currently underway has increased significantly during the past 12 months and the search for treatments that will prevent the progression of MCI to dementia continues. Synexus has teamed up with dementia expert, Dr Roger Bullock, to develop more effective clinical trials for this field.

From AES - Accelerated Enrollment Solutions 16 Nov 2010

Size of hippocampus may be linked to early dementia

The size of the part of the brain known as the hippocampus may be linked to future dementia, reveals a thesis from the University of Gothenburg, Sweden.

16 Nov 2010

Handwriting problems in autistic children likely to continue into teenage years: Study

A new study suggests that the handwriting problems that affect children with autism are likely to continue into their teenage years.

16 Nov 2010

Regular exercise could reduce risk of developing physical, mental health conditions

People who take regular exercise could reduce their risk of developing around two dozen physical and mental health conditions including some cancers and dementia and slow down how quickly their body deteriorates as they age.

15 Nov 2010

Journal of Alzheimer's Disease highlights latest scientific studies of AD

A supplement to the Journal of Alzheimer's Disease on "Anesthetics and Alzheimer's Disease" provides the platform to bring the latest scientific studies to the AD research and clinical communities.

15 Nov 2010

30 seconds to predict possibility of Alzheimer’s disease

It could take a mere 30 seconds to spot signs of Alzheimer’s disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer’s disease is detected much later in life after the symptoms begin to appear.

14 Nov 2010

Eight students to receive Hartford Doctoral Fellowship in geriatric social work

Eight outstanding students have been chosen as the newest recipients of the prestigious Hartford Doctoral Fellowship in geriatric social work. The program is funded by the John A. Hartford Foundation, administered by The Gerontological Society of America, and directed by James Lubben, DSW, MPH.

12 Nov 2010

Seven stages of Alzheimer's disease

Now, during Alzheimer's Awareness month, is an important time to recognize Alzheimer's and its symptoms. Alzheimer's is the most common form of dementia that has a higher risk factor with increasing age. It is a progressive disease that worsens with time. Besides the most common early symptom of Alzheimer's, which is difficulty remembering new information, there are seven stages of Alzheimer's, according to the Alzheimer's Association. It is important to track the different stages to have an understanding and be an efficient caregiver to a loved one.

12 Nov 2010

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic® (nebivolol) and Savella® (milnacipran HCl) in Canada with Janssen Pharmaceutica, NV and Janssen Pharmaceutical respectively, on behalf of Janssen Inc., which will market the products in Canada.

12 Nov 2010

High cholesterol in midlife does not increase risk for Alzheimer's disease among women

High cholesterol levels in middle age do not appear to increase women's risk of developing Alzheimer's disease and other forms of dementia later in life, new Johns Hopkins-led research finds, despite a body of scientific evidence long suggesting a link between the two.

11 Nov 2010

Study suggests mid-life cholesterol level may not linked to later development of Alzheimer's disease

Contrary to earlier research, a new, long-term study suggests that cholesterol level in mid-life may not be linked to later development of Alzheimer's disease, according to a study published in the November 10, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology. However, the results suggest that large decreases in cholesterol levels in old age could be a better predictor of developing the memory-robbing disease.

11 Nov 2010

Depression associated with molecular-level disturbance in body's 24-hour clock

Depression appears to be associated with a molecular-level disturbance in the body's 24-hour clock, new research suggests.

11 Nov 2010

Dementia deaths & incidence on the rise

A new report highlights the fact that one in six deaths are caused by dementia in England. The report looked at death certificates between 2001 and 2009 and found that conditions such as Alzheimer’s disease account for 15 per cent of deaths in England. Two-thirds of victims died in nursing or residential care homes and a third in hospital. Most campaigners claim that the actual figures may be higher and put it as one in three deaths. The report also says that the total number of deaths due to dementia are rising.

10 Nov 2010

Simple test and an MRI predicts future Alzheimer’s disease

Until now is has been believed that Alzheimer’s disease and other forms of dementia could be diagnosed only when symptoms appear which almost always means when patients are in their 70s or 80s. Now the latest research shows that some brain lesions are characteristic of Alzheimer’s disease and can be detected in the brains of healthy people in their 40s. Along with this a simple mental skills test may be able to detect the problem many years sooner than previously thought.

10 Nov 2010

Jefferson awarded $2.6M grant for study on cognitive decline in older African Americans with MCI

Researchers in the Departments of Psychiatry and Neurology at Jefferson Medical College of Thomas Jefferson University were recently awarded a $2.6 million grant from The National Institute of Health to study whether increasing participation in cognitive, physical and/or social activities prevents cognitive decline in older African Americans with Mild Cognitive Impairment (MCI).

10 Nov 2010

18 partner consortium to develop lab-on-a-chip to detect brain diseases

A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.

10 Nov 2010

Experts develop new screening test to detect dementia in elderly patients

Dementia and cognitive impairment are widespread among elderly individuals in the United States, affecting more than 8 million people to some degree.

10 Nov 2010

DHA improves memory function in older adults with mild cognitive impairments

A study published in the November edition of Alzheimer's & Dementia: The Journal of the Alzheimer's Association suggests that taking docosahexaenoic acid (DHA) may improve memory and learning in older adults with mild cognitive impairments. This is promising news for many aging Americans who are searching for options to maintain memory and support overall cognitive health.

9 Nov 2010

Study finds canola-type rapeseed oil decreases fibrinogen level

According to research on fatty acids conducted at the universities of Helsinki and Tampere, the consumption of canola-type rapeseed oil decreases the level of fibrinogen detrimental to health in the body. The increased fibrinogen level, caused by an imbalance in essential fats in one's diet, decreases when saturated fatty acids are replaced with rapeseed oil.

9 Nov 2010

Excess levels of TNF immune signaling protein key factor in AD

Three new studies provide converging evidence pointing to a new therapeutic target in Alzheimer's Disease(AD). These studies, from independent academic centers in the U.S., England, and China, point to excess levels of a protein called TNF as a key factor in AD. TNF is an immune signaling protein that regulates both inflammation and neuronal communication in the brain.

8 Nov 2010